LEVIN JEREMY M
SEC CIK 1256153 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | Executive COB, Dir | 3.74M | $50.4K | — | 5 | 2019-09-20 | 2026-03-23 |
Most active insiders at OVID, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ALEXANDER MARGARET A. | Pres, CEO, Dir | — | $16.9K |
| 2 | Rona Jeffrey A | CBFO | — | $12.4K |
| 3 | Fitzgerald Kevin Joseph | Dir | — | — |
| 4 | Carter Charles Ross | CFO | — | — |
| 5 | Takeda Pharmaceuticals U.S.A., Inc. | 10% | — | — |
| 6 | Friedman Bart | Dir | — | — |
| 7 | LEVIN JEREMY M | Executive COB, Dir | — | — |
| 8 | PAPADOPOULOS STELIOS | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-25 | 2026-03-23 | OVID | Ovid Therapeutics Inc. | LEVIN JEREMY M | Executive COB, Dir | M - OptEx | $1.40 | +47.3K | 3.74M | +1% | +$66.3K |
| D | 2025-12-18 | 2025-12-15 | OVID | Ovid Therapeutics Inc. | LEVIN JEREMY M | CEO, Dir | C - Cnv Deriv | — | +71.0K | 3.69M | +2% | — |
| 2024-03-20 | 2024-03-18 | OVID | Ovid Therapeutics Inc. | LEVIN JEREMY M | CEO, Dir | P - Purchase | $2.76 | +18.2K | 3.62M | +0.5% | +$50.4K | |
| AI | 2024-02-14 | 2019-09-20 | OVID | Ovid Therapeutics Inc. | LEVIN JEREMY M | CEO, Dir | G - Gift | $0.00 | -465.1K | 0 | -100% | $0 |
| M | 2023-12-06 | 2023-12-04 | OVID | Ovid Therapeutics Inc. | LEVIN JEREMY M | CEO, Dir | G - Gift | $0.00 | -1.15M | 4.17M | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations